Key Takeaways Foundayo (orforglipron), approved April 1st, is the first small molecule oral GLP-1 no empty stomach requirement, no cold chain, and potentially lower production costs long-term
Do not drink alcohol or take other medicines that make you sleepy or dizzy while taking valproic acid, until you talk with your doctor
45 Remarkably, the recent SELECT trial proved the cardiovascular efficacy of subcutaneous semaglutide in reducing the primary cardiovascular composite endpoint (death from cardiovascular causes, non-fatal MI or non-fatal stroke) in both overweight and obese patients with established atherosclerotic CVD
Sepp, M
The three-pronged protocol addresses hair loss from three distinct but complementary angles, each targeting a different aspect of follicle regeneration
How do I know which weight loss drug is better for me